Case study: Partnering with the National Cancer Institute to advance COVID-19 research
Background While the COVID-19 pandemic is behind us, the virus remains a concern that needs to be...
Background While the COVID-19 pandemic is behind us, the virus remains a concern that needs to be...
The healthcare industry has moved away from paper charts and file folders in favor of electronic...
The FDA recently released draft guidance that provides details on creating Diversity Action Plans...
As the industry develops increasingly complex treatments to address unmet clinical needs, it is...
Open claims and closed payer claims data are essential for understanding the status and activities...
The FDA often requires some sort of post-market surveillance for medical devices to determine the...
Real-world data (RWD) offers a multitude of use cases that can benefit pharmaceutical companies...
Our series exploring the value of real-world data (RWD) throughout the pharmaceutical product life...
In our ongoing series, we have been discussing the value of real-world data (RWD) throughout the...
Two years ago, HealthVerity launched the Maternal Outcomes Masterset (MOM) to address the...
Background While the COVID-19 pandemic is behind us, the virus remains a concern that needs to be studied. In the first half of 2024 alone, over 23,000 people in the United States died of the disease. The virus also continues to evolve, with the FDA ...